Amyotrophic lateral sclerosis: genes and variants
Explore variant evidence for Amyotrophic lateral sclerosis across 20 analyzed proteins (SOD1, FUS, TARDBP, SETX, OPTN and 15 more). Linked ClinVar records include 146 pathogenic or likely pathogenic variants, 686 variants of uncertain significance and 353 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Amyotrophic lateral sclerosis
SOD1: Superoxide dismutase [Cu-Zn]
It detoxifies superoxide radicals in the cytosol and mitochondrial intermembrane space, limiting oxidative injury. Pathogenic variants cause amyotrophic lateral sclerosis mainly through toxic properties of mutant protein rather than simple loss of antioxidant activity.
104 ClinVar pathogenic / likely pathogenic and 50 uncertain variants in SOD1 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
FUS: RNA-binding protein FUS
It coordinates transcription, RNA processing, transport, and stress-granule dynamics and can shuttle between nucleus and cytoplasm. Pathogenic variants can cause amyotrophic lateral sclerosis through disturbed RNA and protein homeostasis and are also associated with frontotemporal degeneration.
19 ClinVar pathogenic / likely pathogenic and 108 uncertain variants in FUS have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
TARDBP: TAR DNA-binding protein 43
TDP-43 is an RNA-binding protein that regulates RNA processing, splicing, stability, and transport. Its normal activity supports neuronal and muscle cells, while abnormal TDP-43 accumulation is closely associated with amyotrophic lateral sclerosis and frontotemporal degeneration.
12 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in TARDBP have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SETX: Helicase senataxin
It resolves RNA-DNA hybrids and supports transcription termination, RNA processing, and genome stability, particularly in long-lived neurons. Different pathogenic mechanisms cause ataxia with oculomotor apraxia type 2 or juvenile amyotrophic lateral sclerosis type 4.
6 ClinVar pathogenic / likely pathogenic and 603 uncertain variants in SETX have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
OPTN: Optineurin
It serves as an adaptor in selective autophagy, vesicle trafficking, and inflammatory signaling and helps target damaged mitochondria or protein aggregates for clearance. Pathogenic variants can cause amyotrophic lateral sclerosis or certain glaucomas depending on the mechanism.
3 ClinVar pathogenic / likely pathogenic and 143 uncertain variants in OPTN have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
UBQLN2: Ubiquilin-2
It shuttles ubiquitinated proteins toward proteasomal or autophagic degradation and helps maintain protein quality in neurons. Dominant X-linked variants can cause amyotrophic lateral sclerosis with or without frontotemporal dementia through impaired proteostasis.
1 ClinVar pathogenic / likely pathogenic and 90 uncertain variants in UBQLN2 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
ERBB4: Receptor tyrosine-protein kinase erbB-4
It transduces neuregulin and other EGF-family signals important for neural, cardiac, and mammary development. Altered signaling or somatic variants occur in several cancers and have also been studied in neurodevelopmental disease.
1 ClinVar pathogenic / likely pathogenic and 25 uncertain variants in ERBB4 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SQSTM1: Sequestosome-1
SQSTM1, also called p62, is an adapter that connects ubiquitinated cargo to autophagosomes for selective autophagy. It also influences the NRF2 cytoprotective pathway and endosomal organization, and SQSTM1 variants are associated with Paget disease of bone and neurodegeneration.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SQSTM1 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
KIF5A: Kinesin heavy chain isoform 5A
It drives anterograde transport of organelles and proteins along axonal microtubules and is especially important in long motor neurons. Pathogenic variants can cause hereditary spastic paraplegia, axonal Charcot-Marie-Tooth disease, or amyotrophic lateral sclerosis depending on the affected region and mechanism.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in KIF5A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
HNRNPA1: Heterogeneous nuclear ribonucleoprotein A1
It regulates pre-mRNA splicing, RNA transport, translation, and stress-granule dynamics through RNA binding and reversible self-assembly. Rare pathogenic variants can cause multisystem proteinopathy, amyotrophic lateral sclerosis, or related neuromuscular degeneration through altered RNA and protein homeostasis.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in HNRNPA1 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
VCP: Transitional endoplasmic reticulum ATPase
It uses ATP to extract ubiquitinated proteins from complexes or membranes for recycling or degradation and is central to proteostasis, ER-associated degradation, and autophagy. Dominant pathogenic variants cause multisystem proteinopathy with inclusion-body myopathy, Paget disease, frontotemporal dementia, or ALS.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in VCP have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
C9ORF72: Guanine nucleotide exchange factor C9orf72
It participates in endolysosomal trafficking, autophagy, and immune regulation through complexes with SMCR8 and WDR41. A large GGGGCC repeat expansion causes the most common inherited form of amyotrophic lateral sclerosis and frontotemporal dementia.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in C9ORF72 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
GALT: Galactose-1-phosphate uridylyltransferase
It converts galactose-1-phosphate and UDP-glucose into glucose-1-phosphate and UDP-galactose in the Leloir pathway. Biallelic deficiency causes classic galactosemia, in which dietary galactose can lead to neonatal liver failure, sepsis risk, cataracts, and long-term complications.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GALT have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SCN10A: Sodium channel protein type 10 subunit alpha
The protein forms Nav1.8, a tetrodotoxin-resistant voltage-gated sodium channel found in excitable membranes. It helps generate sensory-neuron electrical signals and is especially important in mechanisms of neuropathic pain and inherited episodic pain.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN10A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN1A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SCN2A: Sodium channel protein type 2 subunit alpha
The protein forms Nav1.2, a voltage-gated sodium channel that carries sodium current during neuronal action potentials. By shaping neuronal excitability and signal propagation, it supports brain circuits involved in development, learning, and seizure susceptibility.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN2A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN4A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SCN8A: Sodium channel protein type 8 subunit alpha
The protein forms Nav1.6, a voltage-gated sodium channel that sets the threshold and propagation of neuronal action potentials. It is widely important for neuronal excitability, and SCN8A variants are associated with developmental and epileptic encephalopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN8A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
SCN9A: Sodium channel protein type 9 subunit alpha
The protein forms Nav1.7, a voltage-gated sodium channel that amplifies electrical signals in peripheral sensory neurons. Changes in Nav1.7 activity can produce either excessive pain or congenital insensitivity to pain, making SCN9A central to pain biology.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN9A have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
TBK1: Serine/threonine-protein kinase TBK1
It activates IRF3 and related antiviral pathways after innate immune sensing and also participates in autophagy and cellular homeostasis. Loss-of-function variants can cause amyotrophic lateral sclerosis or frontotemporal dementia, while increased pathway activity can support inflammatory disease and some cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TBK1 have source records linked to Amyotrophic lateral sclerosis. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CHRNA4, ATXN2, CACNA1A, GRN and PON1.
Where Amyotrophic lateral sclerosis variants cluster
- TARDBP Interaction with UBQLN2 (positions 216–414): 10 of 11 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Amyotrophic lateral sclerosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SOD1 A5V | 5 | Pathogenic / likely pathogenic (★★) | |
| SOD1 A5T | 5 | Pathogenic / likely pathogenic (★★) | |
| SOD1 F21L | 21 | Pathogenic / likely pathogenic (★★) | |
| SOD1 N87S | 87 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G94D | 94 | Pathogenic / likely pathogenic (★★) | |
| SOD1 D125V | 125 | Pathogenic / likely pathogenic (★★) | |
| FUS R514G | 514 | Pathogenic / likely pathogenic (★★) | |
| FUS R521G | 521 | Pathogenic / likely pathogenic (★★) | |
| FUS R521L | 521 | Pathogenic / likely pathogenic (★★) | |
| FUS R521C | 521 | Pathogenic / likely pathogenic (★★) | |
| FUS P525L | 525 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V15M | 15 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V15L | 15 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G17A | 17 | Pathogenic / likely pathogenic (★★) | |
| SOD1 Q23L | 23 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G42D | 42 | Pathogenic / likely pathogenic (★★) | |
| SOD1 L85F | 85 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G86R | 86 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G86S | 86 | Pathogenic / likely pathogenic (★★) | |
| SOD1 N87K | 87 | Pathogenic / likely pathogenic (★★) | |
| SOD1 N87D | 87 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V88A | 88 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V88M | 88 | Pathogenic / likely pathogenic (★★) | |
| SOD1 D125G | 125 | Pathogenic / likely pathogenic (★★) | |
| SOD1 L145S | 145 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V149G | 149 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V149I | 149 | Pathogenic / likely pathogenic (★★) | |
| SOD1 I150T | 150 | Pathogenic / likely pathogenic (★★) | |
| TARDBP G294A | 294 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| FUS R521H | 521 | Pathogenic / likely pathogenic (★★) | |
| SOD1 K4E | 4 | Pathogenic / likely pathogenic (★★) | |
| SOD1 A5S | 5 | Pathogenic / likely pathogenic (★★) | |
| SOD1 L39V | 39 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G42S | 42 | Pathogenic / likely pathogenic (★★) | |
| SOD1 H44R | 44 | Pathogenic / likely pathogenic (★★) | |
| SOD1 N66S | 66 | Pathogenic / likely pathogenic (★★) | |
| SOD1 D77Y | 77 | Pathogenic / likely pathogenic (★★) | |
| SOD1 A90V | 90 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G94R | 94 | Pathogenic / likely pathogenic (★★) | |
| SOD1 A96T | 96 | Pathogenic / likely pathogenic (★★) | |
| SOD1 L107V | 107 | Pathogenic / likely pathogenic (★★) | |
| SOD1 N140K | 140 | Pathogenic / likely pathogenic (★★) | |
| SOD1 L145F | 145 | Pathogenic / likely pathogenic (★★) | |
| TARDBP G294V | 294 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| SETX L389S | 389 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G38R | 38 | Pathogenic / likely pathogenic (★★) | |
| SOD1 H47R | 47 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V48A | 48 | Pathogenic / likely pathogenic (★★) | |
| SOD1 H49R | 49 | Pathogenic / likely pathogenic (★★) | |
| SOD1 D77V | 77 | Pathogenic / likely pathogenic (★★) | |
| SOD1 E101G | 101 | Pathogenic / likely pathogenic (★★) | |
| SOD1 E101K | 101 | Pathogenic / likely pathogenic (★★) | |
| SOD1 R116G | 116 | Pathogenic / likely pathogenic (★★) | |
| SOD1 T138I | 138 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G148D | 148 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G13R | 13 | Pathogenic / likely pathogenic (★★) | |
| SOD1 G73S | 73 | Pathogenic / likely pathogenic (★★) | |
| SOD1 V120L | 120 | Pathogenic / likely pathogenic (★★) | |
| TARDBP M337V | 337 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| FUS K510E | 510 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 146.
Uncertain variants prioritized for review in Amyotrophic lateral sclerosis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SOD1 R116C | 116 | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; R116G at the same position is pathogenic; REVEL 0.980 | |
| SOD1 R116H | 116 | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; R116G at the same position is pathogenic; REVEL 0.952 | |
| SOD1 Q23H | 23 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; Q23P at the same position is pathogenic; REVEL 0.808 | |
| SOD1 A90T | 90 | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; A90V at the same position is pathogenic; REVEL 0.820 | |
| TARDBP G295R | 295 | Interaction with UBQLN2 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; G295S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.78 |
| SOD1 G73C | 73 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G73S at the same position is pathogenic; REVEL 0.948 | |
| FUS H517N | 517 | Uncertain (★) | +6: 6 other pathogenic changes within 3 positions; H517Q at the same position is pathogenic; REVEL 0.786 | |
| SOD1 A96V | 96 | Uncertain (★) | +6: 7 other pathogenic changes within 3 positions; A96T at the same position is pathogenic; REVEL 0.844 | |
| SOD1 H72Q | 72 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; H72Y at the same position is pathogenic; REVEL 0.887 |
Which prediction tools work for Amyotrophic lateral sclerosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 89 out of 100
- ESM1b (LLR): 85 out of 100
- EVE: 83 out of 100
- PolyPhen-2: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 81 out of 100
- SIFT: 79 out of 100
- phyloP: 62 out of 100
- SpliceAI: 61 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 also has ClinVar records linked to SETX variants; they fall mostly in different places as the Amyotrophic lateral sclerosis variants (17 pathogenic / likely pathogenic).
Diseases related to Amyotrophic lateral sclerosis
- Cardiac arrhythmia, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 2 more
- Epilepsy, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 2 more
- Focal epilepsy, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 2 more
- Migraine, also linked to SCN10A, SCN1A, SCN2A, SCN4A and 2 more
- Lennox-Gastaut syndrome, also linked to SCN10A, SCN1A, SCN2A, SCN8A and 1 more
- Frontotemporal dementia and/or amyotrophic lateral sclerosis, also linked to C9ORF72, SQSTM1, TBK1 and VCP
- Developmental and epileptic encephalopathy, also linked to SCN1A, SCN2A and SCN8A
- Motor neuron disease, also linked to SOD1, TARDBP and TBK1
- Genetic developmental and epileptic encephalopathy, also linked to SCN1A, SCN2A and SCN8A
- Early-infantile DEE, also linked to SCN1A and SCN8A
- Hereditary spastic paraplegia, also linked to KIF5A and SETX
- Charcot-Marie-Tooth disease, also linked to KIF5A and VCP
Frequently asked questions
Which genes have records linked to Amyotrophic lateral sclerosis?
This view contains 20 analyzed proteins: SOD1, FUS, TARDBP, SETX, OPTN and 15 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 146 pathogenic or likely pathogenic variants, 686 variants of uncertain significance and 353 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,503 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center